Dulcolax Stimulant Laxative Tablet, Coated
NDC Package 41167-0200-2
Package Information
Dulcolax Stimulant Laxative (bisacodyl) tablets is bisacodyl is used to treat constipation. This formulation utilizes a tablet, coated delivery system. Marketed by Chattem, Inc., this product is identified by NDC 41167-0200 and is authorized under FDA application 505G(a)(3).
Identification & Billing
- RxCUI: 209613 - Dulcolax 5 MG Delayed Release Oral Tablet
- RxCUI: 209613 - bisacodyl 5 MG Delayed Release Oral Tablet [Dulcolax]
- RxCUI: 308753 - bisacodyl 5 MG Delayed Release Oral Tablet
- RxCUI: 308753 - bisacodyl 5 MG Enteric Coated Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 41167 - Chattem, Inc.
- 41167-0200 - Dulcolax Stimulant Laxative
- 41167-0200-2 - 1 BLISTER PACK in 1 CARTON / 25 TABLET, COATED in 1 BLISTER PACK
- 41167-0200 - Dulcolax Stimulant Laxative
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (41167-0200). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 41167-0200-2 identifies a specific commercial package of 1 blister pack in 1 carton / 25 tablet, coated in 1 blister pack of Dulcolax Stimulant Laxative, a human over the counter drug labeled by Chattem, Inc.. This tablet, coated is formulated for oral use and contains bisacodyl as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Chattem, Inc. on January 02, 2019. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Bisacodyl is used to treat constipation. It may also be used to clean out the intestines before a bowel examination/surgery. Bisacodyl is known as a stimulant laxative. It works by increasing the movement of the intestines, helping the stool to come out.
How is this Chattem, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 41167020002. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.